US Patent Issued to Vitalis Analgesics on July 28 for "Oral administration of ketamine" (New York Inventor)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,691,082, issued on July 28, was assigned to Vitalis Analgesics LLC (Wilmington, Del.).

"Oral administration of ketamine" was invented by Joseph Habboushe (New York).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are pharmaceutical compositions having a portion of ketamine for intraoral release and another ketamine for gastrointestinal release. The compositions can further include aspirin. The disclosed formulations and related administration approaches improve the bioavailability and efficacy of oral ketamine."

The patent was filed on June 10, 2022, under Application No. 17/837,501.

*For further information, including images, charts and table...